Additionally, CREB4 was observed to moderate glioma proliferation by regulating PI3K/Akt (Li et al., 2021); however, the mechanism of CRB3L4 inhibition in HER2+ breast cancer cells by PGB-0-ol requires further investigation. Here, CREB3L4 is linked to central nervous system cancer.